Scpharmaceuticals Inc (SCPH) Return on Investment ROI from the second quarter of 2025 to second quarter of 2024 and for the year 2025, average high and low, overall ranking from Jun 30 2025 to Jun 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Scpharmaceuticals Inc   (NASDAQ: SCPH)


Scpharmaceuticals Inc's ROI from its second quarter of 2025 to the second quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Scpharmaceuticals Inc's ROI in the second quarter of 2025?
Scpharmaceuticals Inc recorded a cumulative net loss of $-92 million during 12 months ending in the second quarter of 2025, resulting in a negative return on investment (ROI) of -108.89%.

Within the Healthcare sector 721 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2025 quarter, so far to 4231, from total ROI ranking in the first quarter of 2025 at 4294.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter
Y / Y Investment Change TTM 16.12 % -5.17 % -20.54 % -30.08 % -22.63 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 60 75 93 110 51
Return On Investment (TTM) -108.89 % -110.56 % -106.87 % -104.69 % -83.6 %
SCPH's Overall Ranking # 4231 # 4294 # 4923 # 4341 # 4306
Seq. Investment Change TTM 2.58 % 3.06 % 4.11 % 5.5 % -16.22 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -92 -91 -85 -80 -61

SCPH Company Profile >> Back to SCPH Roi Comparisons >> See Annual SCPH Return On Investment



Return On Investment SCPH's Ranking
Within: No.
Industry # 331
Sector # 722
Overall # 4231

Return On Investment Statistics
High Average Low
-9 %
-52.08 %
-109.06 %
(Mar 31 2018)   (Mar 31 2025)







Financial Statements
Scpharmaceuticals Inc's II. Quarter Investments $ 60 Millions SCPH's Balance sheet
Scpharmaceuticals Inc's II. Quarter Income $ -18 Millions Quarterly SCPH's Income Statement
SCPH's Income by Division See SCPH's Income by Division


SCPH Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 93 80 117 64 99
Y / Y Investment Growth 15.71 % -31.44 % 81.91 % -35.32 % 39.58 %
Net Income in Millions -85 -55 -37 -28 -32
Y / Y Net Income Growth - - - - -
Annual Return On Investment -91.91 % -68.46 % -31.55 % -43.67 % -32.45 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SCPH's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SCPH's Competitors
Subscribers only: Roi for Scpharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for SCPH's Customers

Other Ratios
SCPH's Roa SCPH's Inventory Turnover Ratio SCPH's Growth Rates SCPH's Dividend Statistics
SCPH's Profitability Ratios SCPH's Asset Turnover Ratio SCPH's Dividend Growth
SCPH's Roe SCPH's Valuation Ratios SCPH's Financial Strength Ratios SCPH's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2025, within Healthcare Sector ROI

Date modified: 2026-09-26T07:33:43+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.